Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for business professionals · Wednesday, February 26, 2025 · 789,388,849 Articles · 3+ Million Readers

Functional Endoscopic Sinus Surgery Market to Reach USD 1.91 Billion by 2032 | SNS Insider

Functional Endoscopic Sinus Surgery Market

Functional Endoscopic Sinus Surgery Market

Growing Prevalence of Chronic Sinusitis and Advancements in Surgical Techniques Drive Market Growth at a CAGR of 7.66% from 2024 to 2032

AUSTIN, TX, UNITED STATES, February 26, 2025 /EINPresswire.com/ -- According to a report by SNS Insider, the Functional Endoscopic Sinus Surgery Market was valued at USD 1.01 billion in 2023 and is projected to grow at a CAGR of 7.66% over the forecast period, reaching USD 1.91 billion by 2032. This growth is driven by increasing cases of chronic sinusitis, rising preference for minimally invasive procedures, and advancements in surgical technologies.

The increasing prevalence of chronic rhinosinusitis (CRS) and allergic rhinitis is a primary driver of the FESS market. As sinus-related disorders become more widespread, the demand for effective, minimally invasive surgical solutions is on the rise. Additionally, technological advancements in endoscopic equipment, including high-definition imaging and navigation-assisted surgery, are significantly improving surgical outcomes and boosting market adoption.

Get a Free Sample Report@ https://www.snsinsider.com/sample-request/4457

Segmentation Insights

By Product, the endoscopes segment dominated the functional endoscopic sinus surgery market in 2023, capturing 43% of the market share.

Their prevalence is due to their pivotal contribution to improving visualization, accuracy, and safety throughout sinus procedures. The need for technologically improved endoscopes, such as high-definition and 3D endoscopes, keeps on increasing because of better patient results and quicker recoveries.

The most rapidly growing product segment is navigation systems, whose use is growing in FESS procedures at a very fast rate. They increase the accuracy of surgery, minimize complications, and are becoming an essential part of complex sinus surgeries, especially in hospitals and advanced surgical centers.

By Indication, the fungal sinusitis segment led the market in 2023, holding 31% of the overall share.
The dominance of this segment is evident mainly because of the growing incidence of fungal infections, especially in immunocompromised patients and patients with chronic sinus diseases. Growing awareness and enhanced diagnostic tools have also helped in early diagnosis and treatment, driving further growth in segments.

The most rapidly growing indication is chronic rhinosinusitis with nasal polyposis. The growing incidence of this condition, combined with the increasing demand for surgical treatment over prolonged medication use, is driving the uptake of functional endoscopic sinus surgery in these patients.

By Procedure, Frontal sinus surgery emerged as the most dominant procedure in 2023

Because of its common utilization for the treatment of chronic sinus infections and complex cases involving extensive intervention. The operation is commonly done due to the prevalence of frontal sinus diseases and the need for accurate surgical access in such cases.

The most rapidly expanding procedure is ethmoid sinus surgery, whose acceptance continues to rise because of advances in techniques and improved results. Ethmoid sinus surgery is frequently necessary in instances of serious sinus disease and is often combined with other sinus operations.

By End User, Hospitals and ambulatory surgery centers (ASCs) accounted for the largest market share in 2023, capturing a significant portion of the market.

This is because they have access to sophisticated surgical facilities, and skilled professionals, and can perform complicated sinus surgeries more effectively. Hospitals are still the best option for most patients who have FESS surgeries.

The most rapidly expanding segment is specialty clinics, as more and more patients are opting for treatment in outpatient facilities. The cost savings, convenience, and reduced hospital stays of specialty clinics are key drivers of their expansion in the functional endoscopic sinus surgery market.

Speak with Our Expert Analyst Today to Gain Deeper Insights @ https://www.snsinsider.com/request-analyst/4457

Regional Insights

North America led the functional endoscopic sinus surgery market in 2023, accounting for 40% of the global share.

The dominance of the region is because it is endowed with an established healthcare infrastructure, high adoption rates of new-age surgical technology, and increasing incidence of sinus-related diseases. In addition to this, the expanding geriatric population and heightened inclination towards minimal invasiveness enhance the North American market further.

The Asia-Pacific region is likely to be the most rapidly growing market in the next few years. The growth of the region is driven by rising healthcare investments, heightened awareness of minimally invasive sinus surgery, and the growing presence of advanced surgical centers. Furthermore, an increasing number of cases of sinusitis, especially in nations like China and India, is also driving market growth in this region.

Key Players in Functional Endoscopic Sinus Surgery Market
• Olympus
• Stryker Corporation
• Medtronic
• Karl Storz
• Smith & Nephew
• Conmed Corporation
• Johnsons & Johnsons
• Sinusys
• Dalent Medical
• B. Braun Melsungen AG
• and other players.

Buy Full Research Report on Functional Endoscopic Sinus Surgery Market 2024-2032 @ https://www.snsinsider.com/checkout/4457

About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Jagney Dave
SNS Insider Pvt. Ltd
+1 315-636-4242
email us here
Visit us on social media:
Facebook
X
LinkedIn
Instagram

Powered by EIN Presswire

Distribution channels: Healthcare & Pharmaceuticals Industry

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release